Daito Pharmaceutical Co.,Ltd.
JP ˙ TSE ˙ JP3486150000
1.356,00 ¥ ↓ -15,00 (-1,09%)
2026-10-19
AKTIENPREIS
SecurityJP:4577 / Daito Pharmaceutical Co.,Ltd.
InstitutionDISV - Dimensional International Small Cap Value ETF
Latest Disclosed Ownership151,152 shares
Latest Disclosed Value $ 1,216,315
DISV - Dimensional International Small Cap Value ETF reports 9.89% increase in ownership of 4577 / Daito Pharmaceutical Co.,Ltd.

On June 29, 2026 - DISV - Dimensional International Small Cap Value ETF filed a NPORT-P form disclosing ownership of 151,152 shares of Daito Pharmaceutical Co.,Ltd. (JP:4577) valued at $190,602,672 USD as of April 30, 2026. The entity filed a previous NPORT-P on March 27, 2026 disclosing 137,552 shares of Daito Pharmaceutical Co.,Ltd.. This represents a change in shares of 9.89% during the quarter. The current value of the position is $204,962,112 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-06-29 2026-04-30 NP DAITO PHARMACEUTICAL EC JP3486150000 151,152 13,600 9.89 1,216 2.27 0.0262
2026-03-27 2026-01-31 NP DAITO PHARMACEUTICAL EC JP3486150000 137,552 4,400 3.30 1,190 10.60 0.0267
2025-12-29 2025-10-31 NP DAITO PHARMACEUTICAL EC JP3486150000 133,152 12,100 10.00 1,075 10.60 0.0293
2025-09-25 2025-07-31 NP DAITO PHARMACEUTICAL EC JP3486150000 121,052 76,926 174.33 972 51.17 0.0300
2025-06-26 2025-04-30 NP DAITO PHARMACEUTICAL EC JP3486150000 44,126 4,600 11.64 644 21.55 0.0230
2025-03-28 2025-01-31 NP DAITO PHARMACEUTICAL EC JP3486150000 39,526 800 2.07 530 -6.87 0.0228
2024-12-30 2024-10-31 NP DAITO PHARMACEUTICAL EC JP3486150000 38,726 15,326 65.50 569 52.69 0.0267
2024-09-27 2024-07-31 NP DAITO PHARMACEUTICAL EC JP3486150000 23,400 -500 -2.09 372 -2.87 0.0180
2024-06-26 2024-04-30 NP DAITO PHARMACEUTICAL EC JP3486150000 23,900 2,900 13.81 383 35.34 0.0211
2024-03-28 2024-01-31 NP DAITO PHARMACEUTICAL EC JP3486150000 21,000 10,400 98.11 284 111.19 0.0178
2023-12-28 2023-10-31 NP DAITO PHARMACEUTICAL EC JP3486150000 10,600 8,000 307.69 135 219.05 0.0105
2023-09-27 2023-07-31 NP DAITO PHARMACEUTICAL EC JP3486150000 2,600 0 0.00 43 -12.50 0.0034
2023-06-26 2023-04-30 NP DAITO PHARMACEUTICAL EC JP3486150000 2,600 700 36.84 48 26.32 0.0047
2023-03-30 2023-01-31 NP DAITO PHARMACEUTICAL EC JP3486150000 1,900 0 0.00 38 18.75 0.0045
2022-12-27 2022-10-31 NP DAITO PHARMACEUTICAL EC JP3486150000 1,900 0 0.00 33 -13.51 0.0069
2022-09-29 2022-07-31 NP DAITO PHARMACEUTICAL EC JP3486150000 1,900 1,900 38 0.0114
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.